Cryptocurrencies
Jim Cramer turns bullish on health care stock after years of doubt
For most of the past three years, Jim Cramer kept his distance from Moderna, treating the biotech stock with skepticism bordering on avoidance. The Cambridge, Massachusetts, company had become synonymous with the pandemic trade, and Read more…